Safety and efficacy of skimune tablet and gel with respect to psoriasis

Authors : Nimish Vador, Bhavesh Vador

DOI : 10.18231/j.ijced.2020.001

Volume : 6

Issue : 1

Year : 2020

Page No : 1-4

Psoriasis is an autoimmune disorder. It is characterized by chronic inflammatory condition of skin. It
leads to thick, scaly plaques on skin . Current medication involves symptomatic treatment by the various
moisturizers, however, the effects do not last long and recurrence occurs. Based on several ancient text
a combination of herbs was formulated and named as Skimune tablet and Gel. Preclinical safety was
conducted which was found to be safe for the dose above 5000 mg/kg of body weight. The beneficial
effects of Skimune Tablet and Gel was clinically evaluated on patients with mild to moderate psoriasis. The
Dermatology Life Quality Index (DLQI) and Psoriasis area & severity index (PASI) score was evaluated to
understand the effects of tablet and Gel. Skimune tablet was found to be safe upto 5000mg/kg of body
weight in animals and was well tolerated in patients too. Skimune Tablet and Gel showed significant
improvement (P <0>

Keywords: Skimune, Psoriasis, Ayurveda, Inflammation, Chronic.


Citation Data